Navigation Links
Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
Date:2/23/2009

Our management uses these non-GAAP financial measures to monitor and evaluate our operating results and trends on an on-going basis and internally for operating, budgeting and financial planning purposes. Our management believes the non-GAAP information is useful for investors by offering them the ability to better identify trends in our business and better understand how management evaluates our business. These non-GAAP measures have limitations, however, because they do not include all items of income and expense that affect Onyx. These non-GAAP financial measures that our management uses are not prepared in accordance with, and should not be considered in isolation of, or an as alternative to, measurements required by GAAP. (4) Employee stock-based compensation under FAS 123R: Our management excludes the effects of employee stock-based compensation because of varying available valuation methodologies, subjective assumptions and the variety of award types; such exclusion facilitates comparisons of our operating results to our peer companies.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. UPDATE: P&M Corporate Finance Announces Partnership with Robin Young to Present the Fifth Annual Spine Technology Summit
2. UPDATE: HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services
3. Economic Update: You Should Invest (in Your Appearance)
4. TCT update: press conference schedule announced for TCT
5. UPDATE: Defense Health Board Traumatic Brain Injury Family Caregivers Panel
6. UPDATE: Celebrating UC Success Announces Essay Contest Winners
7. UPDATE: Retirement Living TV Partners With Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
8. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
9. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
10. Skin Cancer Prevention Update:
11. Update: SpineMark Expands Management Team to Build Spine Care Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... (PRWEB) November 18, 2014 Financing ... focused on innovative financing for international development, has ... Directors. Membership includes six Directors: Mr. John Skibiak ... Bent of the Millennium Challenge Corporation, Mr. Pape ... Total Impact Advisors, Mr. Aron Betru of Financing ...
(Date:11/18/2014)... TN (PRWEB) November 18, 2014 ... company for pharmaceutical, nutraceutical, dietary supplements and more, ... awarded NSF International’s Good Manufacturing Practices (GMP) Registration ... Earning GMP registration from NSF International verifies the ... safety and quality compliance requirements of its clients ...
(Date:11/18/2014)... Hispanic women who,ve had at least five children are much ... than those who,ve had fewer children or none, a new ... Aggarwal of Wake Forest School of Medicine analyzed data on ... York City and San Diego. About 12 percent of them ... type of heart trouble called ventricular diastolic dysfunction -- an ...
(Date:11/18/2014)... Until recently, insect-transmitted Chagas disease was found mainly in Latin ... to the United States over the past few years. ... bite of the "kissing bug," which feeds on the faces ... that common bedbugs might be carriers as well. "We,ve ... Our next step is to determine whether they are, or ...
(Date:11/17/2014)... Home Care Assistance – Halton/Peel Region ( ... senior care, is advising seniors to make sure they ... the immune system and makes it more difficult to ... a greater concern at this time of year, when ... year’s influenza season (November to March), over 5,200 adults ...
Breaking Medicine News(10 mins):Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 3
... trials show some success in helping children , FRIDAY, ... effective in treating juvenile rheumatoid arthritis, according to studies ... (ACR) meeting in Boston. , One study found that ... rheumatoid arthritis, may be a well-tolerated treatment for children ...
... researchers have shown that an immunosuppressive drug used in ... patients with systemic lupus erythematosus (SLE). SLE results in ... joints and kidneys. Its cause is unknown. The findings ... American College of Rheumatology in Boston. , Our findings ...
... Rural/Metro,Corporation (Nasdaq: RURL ) announced it will ... 30, 2007 and fiscal 2007 fourth quarter,and 12 months ... on November,14, 2007. In conjunction, the Company will host ... at 9 a.m. (Pacific)/ 11 a.m.,(Eastern). Also on ...
... Hooper Holmes,Inc. (Amex: HH ), a leading ... the third quarter ended September 30,2007. Third quarter ... the corresponding period of 2006. The Company recorded a ... million, or $(0.16) per share,compared to a net loss ...
... The Signature,Wounds of Operation Iraqi Freedom and ... Veterans for America,s,"Trends in Treatment of ... trends adversely affecting servicemembers and veterans,suffering from ... - traumatic,brain injury (TBI) and psychological traumas., ...
... N.C., EXTON, Pa. and SAN DIEGO, Nov. 9 ... US,provider of oncology equipment sales and service, announced ... with Radiology Oncology Systems, Inc.,(ROS), an oncology and ... Inc., a US provider of oncology equipment service,and ...
Cached Medicine News:Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 3Health News:Hooper Holmes Announces Third Quarter 2007 Results 4Health News:Hooper Holmes Announces Third Quarter 2007 Results 5Health News:Hooper Holmes Announces Third Quarter 2007 Results 6Health News:Hooper Holmes Announces Third Quarter 2007 Results 7Health News:Report Release: Veterans for America Finds Care for PTSD and TBI Inadequate 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3
(Date:11/18/2014)... 2014  AgeneBio, a pharmaceutical company developing innovative ... brain function, today announced that the Company,s founder ... PhD, has received the Society for Neuroscience,s Mika ... years, Dr. Gallagher,s research at Johns Hopkins and ... has led to advancements in the field of ...
(Date:11/17/2014)... Nov. 17, 2014 Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that Jane ... Development, will participate in a live Google Hangout session ... discussing the latest progress in stem cell-based therapies for ... Hangout session is scheduled for Tuesday, November 18, 2014, ...
(Date:11/17/2014)... , November 17, 2014 ... Boston on 20 November   ... discovery and development company, is pleased to announce that ... as one of ten top projects in neuroscience by ... Grau will present an overview of the programme ...
Breaking Medicine Technology:AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Heptares First-in-Class Selective Muscarinic Agonists Chosen as one of top Neuroscience Projects to Watch 2
... AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ("AcelRx"), a ... innovative therapies for the treatment of acute or breakthrough pain, ... ended December 31, 2010. Net loss for the ... common share, compared with a net loss of $3.7 million, ...
... 23, 2011 Actavis Group, an international generic pharmaceuticals ... the US Food & Drug Administration to market Valacyclovir ... 500mg and 1 gram, the generic equivalent of Valtrex® ... for the 12 months ending December 31, 2010, according ...
Cached Medicine Technology:AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 2AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 3AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 4AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 5AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 6Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S. 2
For the quantitative determination of Alkaline Phosphatase in serum. Linearity: 800 IU/L at 37C. P-nitrophenyl phosphate substrate....
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
For determination of uric acid in serum, plasma or urine. For Hitachi 704 / 911. Available with Calibrator: Trucal U and controls: Trulab N and Trulab P....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
Medicine Products: